![Taylor Harris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Taylor Harris
Directeur/Bestuurslid bij
PROCEPT BIOROBOTICS CORPORATION
Vermogen: 3 M $ op 30-06-2026
Profiel
Taylor C.
Harris is currently an Independent Director at PROCEPT BioRobotics Corp.
since 2020, a Director at Establishment Labs Holdings, Inc. starting in 2026, and Chief Financial Officer at Synthego Corp.
since 2022.
Former roles include Chief Executive Officer at Cutera, Inc. in 2023; Director at HealthCor Catalio Acquisition Corp.; Director at Endologix LLC from 2020 to 2023; Director at Omada Health, Inc. from 2021 to 2023; Vice President-Healthcare Investment Banking at JPMorgan Chase & Co. from 1998 to 2010; Associate Analyst at JPMorgan Securities LLC from 2009 to 2010; Chief Financial Officer at MyoKardia, Inc. from 2018 to 2020; Chief Financial Officer & Vice President at Thoratec Corp.
from 2014 to 2015; and Chief Financial Officer & Senior Vice President at ZELTIQ Aesthetics, Inc. from 2016 to 2017.
Education includes an undergraduate degree from The University of North Carolina at Chapel Hill, conferred in 1998.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-06-2026 | 137.565 ( 0,24% ) | 3 M $ | 30-06-2026 | |
| 24-06-2026 | 3.230 ( 0,01% ) | 277 166 $ | 30-06-2026 |
Actieve functies van Taylor Harris
| Bedrijven | Functie | Begin |
|---|---|---|
| PROCEPT BIOROBOTICS CORPORATION | Directeur/Bestuurslid | 01-12-2020 |
| ESTABLISHMENT LABS HOLDINGS INC. | Directeur/Bestuurslid | 24-06-2026 |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Financieel Directeur/CFO | 01-09-2022 |
Eerdere bekende functies van Taylor Harris
| Bedrijven | Functie | Einde |
|---|---|---|
| OMADA HEALTH, INC. | Directeur/Bestuurslid | 01-08-2023 |
| ENDOLOGIX, INC. | Directeur/Bestuurslid | 01-08-2023 |
| MYOKARDIA, INC. | Financieel Directeur/CFO | 01-11-2020 |
| ZELTIQ AESTHETICS INC | Financieel Directeur/CFO | 01-04-2017 |
| THORATEC CORPORATION | Financieel Directeur/CFO | 02-10-2015 |
Opleiding van Taylor Harris
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
96
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Thoratec Corp.
 Thoratec Corp. Medical SpecialtiesHealth Technology Manufactures and distributes circulatory support devices for heart failure patients | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for the interventional treatment of vascular disease | Health Technology |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Cutera, Inc.
 Cutera, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of dermatological problems | Health Technology |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops non-invasive procedures for the reduction of unwanted fat tissue | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
PROCEPT BioRobotics Corp.
 PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omada Health, Inc.
 Omada Health, Inc. Internet Software/ServicesTechnology Services Operates as a virtual care program that pairs with a care team and resources to help your health goals | Technology Services |
Establishment Labs Holdings, Inc.
 Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
HealthCor Catalio Acquisition Corp.
 HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Kies MarketScreener 
